Cambridge Laboratories Jobs Profile

This profile is a brief introduction for people seeking employment in pharmaceutical graduate jobs, pharmaceutical nurse advisors, pharmaceutical sales jobs, pharmaceutical training jobs, pharmaceutical sales management jobs, pharmaceutical marketing jobs, pharmaceutical executive jobs, or pharmaceutical clinical research associates who may be considering working for Cambrdige Laboratories. 

 Company Overview

Cambridge is a successful and progressive healthcare company with an international focus. With offices in Ireland and the UK Cambridge specialise in the development, global registration, marketing, sales and distribution of innovative and classic specialist secondary care pharmaceutical products. Our products, which we have in-licensed or purchased outright from world-class partner companies, provide benefit in high profile therapeutic areas including the Central Nervous System (CNS) and Oncology.

Cambridge's success has been as a result of its management team, which consists of dynamic individuals who have the skills, expertise and vision to build winning brands. Our board of directors includes some of the most respected and renowned professionals in the healthcare industry. Our vision is to become a leading provider of specialist pharmaceuticals for secondary care physicians. We will achieve this by developing market leading brands from targeted acquisitions and internal product development.


Product Overview

Cambridge's current product portfolio consists of 23 products in the following areas:
- Central Nervous System (CNS)
- Oncology
- Specialist Niche Hospital Products

Flag-ship brands within our portfolio include:
- Gelclair® - For oral lesions due to Chemotherapy and Radiotherapy.
- ImmuCyst® 81mg- For treatment of superficial bladder cancer
- Nabilone Capsules- for treatment of nausea and vomiting associated with chemotherapy treatment.
- XenazineTM, NitomanTM (tetrabenazine)- for Hyperkinetic movement disorders, I.e. Huntingtons disease.
- Volplex® - For patients who suffer massive blood loss, as a consequence of haemorrhage, trauma or surgery, the priority is to restore blood volume. Plasma expanders are used to bridge the gap until blood for transfusion is available and in some cases their use can eliminate the need for transfusions altogether.



Laura
Cambridge Laboratories Account Manager
01494 818 035
(Mon to Fri 0830 to 1800 hours)
laura@zenopa.com

Please contact the Account Manager for opportunities with this organisation

News

Cambridge Laboratories hails success of lead product
Cambridge Laboratories has hailed the ongoing success of its lead product Xenazine (tetrabenazine).Xenazine is a highly-selective reversible dopamine depletor that operates by inhibiting monoamine tra...

Cambridge Laboratories makes double promotion
Cambridge Laboratories has promoted two of its management staff in a move designed to strengthen the development capacity of its pharmaceuticals operation.

Cambridge Laboratories announces staff promotions
Cambridge Laboratories has announced the promotion of Dr Andrew Duffield to the position of head of product development and regulatory affairs.

Cambridge Laboratories launches Xenazina in Italy
Cambridge Laboratories has announced that its distribution partner Chiesi Group has launched its dopamine depleting agent Xenazina in Italy following approval by the Agenzia Italiana del Farmaco.

Cambridge Laboratories and Temmler Pharma launch Nitoman
Cambridge Laboratories has announced that its German distribution partner Temmler Pharma has launched the dopamine depletion agent Nitoman.


home | our clients | browse news | browse jobs | links | hotel directory | copyright © 2008 Zenopa Ltd | terms & conditions of use